REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 310 filers reported holding REPLIGEN CORP in Q1 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,183,771 | +19.2% | 485,400 | +6.1% | 0.01% | +33.3% |
| Q2 2023 | $64,739,862 | +5.0% | 457,653 | +25.0% | 0.01% | -14.3% |
| Q1 2023 | $61,644,680 | -12.3% | 366,147 | -11.8% | 0.01% | -12.5% |
| Q4 2022 | $70,317,490 | +42.6% | 415,318 | +57.6% | 0.01% | +14.3% |
| Q3 2022 | $49,318,000 | +35.4% | 263,564 | +17.5% | 0.01% | +40.0% |
| Q2 2022 | $36,419,000 | +35.1% | 224,257 | +56.4% | 0.01% | +25.0% |
| Q1 2022 | $26,967,000 | -19.0% | 143,368 | +14.1% | 0.00% | 0.0% |
| Q4 2021 | $33,279,000 | +29.2% | 125,657 | +41.0% | 0.00% | +33.3% |
| Q3 2021 | $25,762,000 | +5.0% | 89,146 | -27.5% | 0.00% | 0.0% |
| Q2 2021 | $24,529,000 | +8.9% | 122,884 | +6.1% | 0.00% | 0.0% |
| Q1 2021 | $22,516,000 | +7.2% | 115,821 | +5.6% | 0.00% | 0.0% |
| Q4 2020 | $21,011,000 | +145.6% | 109,651 | +89.1% | 0.00% | +50.0% |
| Q3 2020 | $8,556,000 | +73.7% | 57,988 | +45.5% | 0.00% | +100.0% |
| Q2 2020 | $4,926,000 | +52.2% | 39,858 | +18.9% | 0.00% | 0.0% |
| Q1 2020 | $3,236,000 | -71.3% | 33,518 | -72.5% | 0.00% | -66.7% |
| Q4 2019 | $11,256,000 | -41.3% | 121,688 | -51.4% | 0.00% | -40.0% |
| Q3 2019 | $19,190,000 | +8.5% | 250,215 | +21.6% | 0.01% | 0.0% |
| Q2 2019 | $17,688,000 | +99.6% | 205,796 | +37.2% | 0.01% | +66.7% |
| Q1 2019 | $8,862,000 | -51.5% | 149,982 | -56.7% | 0.00% | -40.0% |
| Q4 2018 | $18,276,000 | +29.9% | 346,522 | +36.6% | 0.01% | +25.0% |
| Q3 2018 | $14,072,000 | +75.5% | 253,733 | +48.8% | 0.00% | +100.0% |
| Q2 2018 | $8,020,000 | +142.8% | 170,507 | +86.8% | 0.00% | +100.0% |
| Q1 2018 | $3,303,000 | -17.3% | 91,271 | -17.1% | 0.00% | 0.0% |
| Q4 2017 | $3,993,000 | +46.9% | 110,076 | +55.1% | 0.00% | 0.0% |
| Q3 2017 | $2,719,000 | +42.4% | 70,955 | +53.9% | 0.00% | 0.0% |
| Q2 2017 | $1,910,000 | -58.8% | 46,098 | -65.0% | 0.00% | 0.0% |
| Q1 2017 | $4,640,000 | -28.5% | 131,798 | -37.4% | 0.00% | 0.0% |
| Q4 2016 | $6,494,000 | +801.9% | 210,640 | +782.9% | 0.00% | – |
| Q3 2016 | $720,000 | -76.9% | 23,859 | -79.1% | 0.00% | -100.0% |
| Q2 2016 | $3,119,000 | -44.4% | 113,966 | -45.6% | 0.00% | -50.0% |
| Q1 2016 | $5,613,000 | +62.8% | 209,309 | +71.7% | 0.00% | +100.0% |
| Q4 2015 | $3,448,000 | -23.6% | 121,884 | -24.8% | 0.00% | -50.0% |
| Q3 2015 | $4,513,000 | +83.5% | 162,074 | +172.0% | 0.00% | +100.0% |
| Q2 2015 | $2,459,000 | +250.8% | 59,589 | +158.2% | 0.00% | – |
| Q1 2015 | $701,000 | +102.0% | 23,078 | +31.7% | 0.00% | – |
| Q4 2014 | $347,000 | -79.1% | 17,524 | -79.0% | 0.00% | -100.0% |
| Q3 2014 | $1,663,000 | -33.2% | 83,542 | -23.5% | 0.00% | 0.0% |
| Q2 2014 | $2,490,000 | +113.9% | 109,241 | +20.6% | 0.00% | – |
| Q1 2014 | $1,164,000 | -6.0% | 90,575 | -0.2% | 0.00% | -100.0% |
| Q4 2013 | $1,238,000 | +85.1% | 90,754 | +50.5% | 0.00% | – |
| Q3 2013 | $669,000 | -24.2% | 60,315 | -43.7% | 0.00% | – |
| Q2 2013 | $883,000 | – | 107,184 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |